Evidence map›Paper›PMID 36902240›Full record

ReviewInternational journal of molecular sciences2023

Activation of Mast Cells by Neuropeptides: The Role of Pro-Inflammatory and Anti-Inflammatory Cytokines.

Dorina Lauritano, Filiberto Mastrangelo, Cristian D'Ovidio, Gianpaolo Ronconi, Alessandro Caraffa, Carla E Gallenga, Ilias Frydas, Spyros K Kritas, Matteo Trimarchi, Francesco Carinci and 1 more

Open access · goldFull text readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 2 pooled it
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 2 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. MRGPRX2 as a novel therapeutic target in headache.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Editorial Board Members' Collection Series: "Neuroinflammation".International journal of molecular sciences · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Bidirectional Interplay Between Microglia and Mast Cells.International journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 2 countries.

Dorina LauritanoDepartment of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.ORCID 0000-0002-3550-1812
Filiberto MastrangeloDepartment of Clinical and Experimental Medicine, School of Dentistry, University of Foggia, 71100 Foggia, Italy.
Cristian D'OvidioSection of Legal Medicine, Department of Medicine and Aging Sciences, G. d'Annunzio University of Chieti-Pescara, 66100 Chieti, Italy.ORCID 0000-0002-5801-8444
Gianpaolo RonconiClinica dei Pazienti del Territorio, Fondazione Policlinico Gemelli, 00185 Rome, Italy.
Alessandro CaraffaSchool of Pharmacy, University of Camerino, 62032 Camerino, Italy.
Carla E GallengaSection of Ophthalmology, Department of Biomedical Sciences and Specialist Surgery, University of Ferrara, 44121 Ferrara, Italy.ORCID 0000-0002-7426-8603
Ilias FrydasDepartment of Parasitology, Aristotle University, 54124 Thessaloniki, Greece.
Spyros K KritasDepartment of Microbiology and Infectious Diseases, School of Veterinary Medicine, Aristotle University of Thessaloniki, 54124 Macedonia, Greece.ORCID 0000-0002-3540-9928
Matteo TrimarchiCentre of Neuroscience of Milan, Department of Medicine and Surgery, University of Milan, 20122 Milano, Italy.ORCID 0000-0001-6472-3484
Francesco CarinciDepartment of Morphology, Surgery and Experimental Medicine, University of Ferrara, 44121 Ferrara, Italy.
Pio ContiImmunology Division, Postgraduate Medical School, University of Chieti, 66100 Chieti, Italy.ORCID 0000-0002-9475-4924
University of Ferrara · ITAristotle University of Thessaloniki · GRUniversity of Chieti-Pescara · ITAgostino Gemelli University Polyclinic · ITUniversità di Camerino · ITUniversity of Foggia · ITUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mast cells (MCs) are tissue cells that are derived from bone marrow stem cells that contribute to allergic reactions, inflammatory diseases, innate and adaptive immunity, autoimmunity, and mental disorders. MCs located near the meninges communicate with microglia through the production of mediators such as histamine and tryptase, but also through the secretion of IL-1, IL-6 and TNF, which can create pathological effects in the brain. Preformed chemical mediators of inflammation and tumor necrosis factor (TNF) are rapidly released from the granules of MCs, the only immune cells capable of storing the cytokine TNF, although it can also be produced later through mRNA. The role of MCs in nervous system diseases has been extensively studied and reported in the scientific literature; it is of great clinical interest. However, many of the published articles concern studies on animals (mainly rats or mice) and not on humans. MCs are known to interact with neuropeptides that mediate endothelial cell activation, resulting in central nervous system (CNS) inflammatory disorders. In the brain, MCs interact with neurons causing neuronal excitation with the production of neuropeptides and the release of inflammatory mediators such as cytokines and chemokines. This article explores the current understanding of MC activation by neuropeptide substance P (SP), corticotropin-releasing hormone (CRH), and neurotensin, and the role of pro-inflammatory cytokines, suggesting a therapeutic effect of the anti-inflammatory cytokines IL-37 and IL-38.

Indexed as

CytokinesMast CellsNeuropeptidesAnimalsHumansInflammationInterleukinsMiceRatsSubstance PTumor Necrosis Factor-alphaCytokinesIL-38 protein, humanInterleukinsNeuropeptidesSubstance PTumor Necrosis Factor-alphaallergycytokinesimmunityinflammationmast cellneuropeptidetumor

Identifiers

PMID36902240
PMCPMC10002992
OpenAlexW4322770802

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read8
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.